Goldman Sachs analyst Andrea Newkirk initiates coverage on 89bio Inc. (NASDAQ: ETNB) with a Neutral rating and a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE